MedTrace Logo

Biomarkers Study in Pancreatic Cancer

NCT01666184 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2012-08-16

No results posted yet for this study

Summary

Study Design:

Patients are eligible if (1) enrolled to TCOG 3207(2) received surgery or biopsy for pancreatic cancer; (3) willing to sign informed consent.

The pancreatic tumor, tissue specimen and blood sample before or after treatment will be collected from department of pathology, surgery or diagnostic medicine.

Conditions

  • Biomarkers Study in Pancreatic Cancer

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • Mackay Memorial Hospital

    collaborator OTHER

  • Taichung Veterans General Hospital

    collaborator OTHER

  • National Cheng-Kung University Hospital

    collaborator OTHER

  • Kaohsiung Veterans General Hospital.

    collaborator OTHER

  • Kaohsiung Medical University

    collaborator OTHER

  • National Health Research Institutes, Taiwan

    lead OTHER

Principal Investigators

  • Yi-Ming Shyr, M.D. · Taipei Veterans General Hospital, Taiwan

  • Tsann-Long Hwang, M.D. · Chang Gung Memorial Hospital

  • Ruey-Kuen Hsieh, M.D. · Mackay Memorial Hospital Taipei, Taiwan

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-08-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01666184 on ClinicalTrials.gov